Polymorphism 2012
19 - 20 December 2012
Two-day conference
Mumbai, India
This two-day event will feature in-depth discussions on specific R&D, analytical, regulatory and IP challenges faced with respect to polymorphs.
Industry experts already confirmed to speak at the event include Rolf Hilfiker, Vice President, Solvias AG (Switzerland); Samir Haddouchi, Managing Director, SPS Pharma (France); Suresh Venkataram, Chief Scientific Officer, Semler Research Centre; Preetam Ghogale, Head Preformulations, Piramal Healthcare; Sharmistha Pal, Research Scientist I, AstraZeneca, among others.
Organiser: UBM